|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: PRAXIS PHARMACEUTICALS INC/CN, 10KSB/A, 2000-10-13 |
Next: PRAXIS PHARMACEUTICALS INC/CN, 10SB12G/A, 2000-10-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE AUDITED
FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED MAY 31, 2000 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C> <C>
<PERIOD-TYPE> YEAR YEAR
<FISCAL-YEAR-END> MAY-31-2000 MAY-31-1999
<PERIOD-START> JUN-01-1999 JUN-01-1998
<PERIOD-END> MAY-31-2000 MAY-31-1999
<EXCHANGE-RATE> 1 1
<CASH> 197,124 103,513
<SECURITIES> 0 0
<RECEIVABLES> 0 0
<ALLOWANCES> 0 0
<INVENTORY> 0 0
<CURRENT-ASSETS> 245,872 103,513
<PP&E> 0 0
<DEPRECIATION> 0 0
<TOTAL-ASSETS> 245,872 103,513
<CURRENT-LIABILITIES> 121,944 119,910
<BONDS> 0 0
0 0
0 0
<COMMON> 862,140 682,140
<OTHER-SE> (738,210) (698,537)
<TOTAL-LIABILITY-AND-EQUITY> 245,872 103,513
<SALES> 0 0
<TOTAL-REVENUES> 0 0
<CGS> 0 0
<TOTAL-COSTS> 0 0
<OTHER-EXPENSES> 203,175 518,574
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 0 16,667
<INCOME-PRETAX> (203,175) (535,241)
<INCOME-TAX> 0 0
<INCOME-CONTINUING> (203,175) (535,241)
<DISCONTINUED> 0 0
<EXTRAORDINARY> (26,998) 0
<CHANGES> 0 0
<NET-INCOME> (230,173) (535,241)
<EPS-BASIC> (0.02) (0.07)
<EPS-DILUTED> (0.02) (0.07)
</TABLE>
|
|